We are live on ! Find out more
CSBR icon

Champions Oncology
CSBR

15 hedge funds and large institutions have $10.7M invested in Champions Oncology in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.3% more ownership

Funds ownership: 37.7% → 38% (+0.3%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6% less funds holding

Funds holding: 16 → 15 (-1)

18% less capital invested

Capital invested by funds: $13.1M → $10.7M (-$2.4M)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
15
Holders Change
-1
Holders Change %
-6.25%
% of All Funds
0.37%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
4
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SKK
Shepherd Kaplan Krochuk
Massachusetts
+$44.4K
2
Renaissance Technologies
Renaissance Technologies
New York
+$36.5K
3
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
+$9.94K
4
UBS Group
UBS Group
Switzerland
+$3.19K
5
PA
Perceptive Advisors
New York
+$3

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$7K
2
Deutsche Bank
Deutsche Bank
Germany
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
BPI
1
Battery Partners IX
Massachusetts
$5.02M – – –
NMC
2
NEA Management Company
Maryland
$4.02M – – –
PA
3
Perceptive Advisors
New York
$943K +$3 +1 +0%
Vanguard Group
4
Vanguard Group
Pennsylvania
$194K – – –
SM
5
Sabby Management
Florida
$184K – – –
SKK
6
Shepherd Kaplan Krochuk
Massachusetts
$106K +$44.4K +17,000 +71%
SIM
7
Spark Investment Management
New York
$103K – – –
Commonwealth Equity Services
8
Commonwealth Equity Services
Massachusetts
$53K +$9.94K +3,807 +23%
Renaissance Technologies
9
Renaissance Technologies
New York
$36K +$36.5K +14,000 New
SSB
10
Sandy Spring Bank
Maryland
$21K – – –
Acadian Asset Management
11
Acadian Asset Management
Massachusetts
$14K – – –
UBS Group
12
UBS Group
Switzerland
$14K +$3.19K +1,223 +29%
Morgan Stanley
13
Morgan Stanley
New York
$9K – – –
JP Morgan Chase
14
JP Morgan Chase
New York
$6K – – –
VIMU
15
Veritas Investment Management (UK)
United Kingdom
$5K – – –
Bank of America
16
Bank of America
North Carolina
– -$7K -2,144 Closed
Deutsche Bank
17
Deutsche Bank
Germany
– -$2K -841 Closed

CSBR Hedge Fund Activity: Q2 2017 in Review

15 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q2 2017, worth a combined $10.7M — down 18% from $13.1M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of CSBR and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 4 added.

The largest buyer was Shepherd Kaplan Krochuk, adding an estimated $44.4K. The largest seller was Bank of America, exiting entirely with an estimated $7K sold.

  • 15 institutional investors held Champions Oncology (CSBR) as of Q2 2017, down from 16 in Q1 2017.
  • Funds reported $10.7M of Champions Oncology stock for Q2 2017, down 18% quarter-over-quarter.
  • 1 fund opened new Champions Oncology positions in Q2 2017 and 2 closed out, a net change of -1 holder.
  • The largest Champions Oncology buyer in Q2 2017 was Shepherd Kaplan Krochuk, an estimated $44.4K added.
  • The largest Champions Oncology seller in Q2 2017 was Bank of America, an estimated $7K sold.

Based on aggregated 13F filings for Q2 2017.